Reshaping the Regulatory Landscape for the Chinese MedTech Industry

Ting Wu of Haiwen & Partners discusses how the recently introduced Medical Device Regulations will impact consumers and companies in the MedTech industry by highlighting major breakthroughs provided by the legislation while at the same time striking a balance with compliance

11 minute readMay 20, 2021 at 11:45 PM

Susan Mok

Reshaping the Regulatory Landscape for the Chinese MedTech Industry

The Chinese government recently released the new Regulations for the Regulation of Medical Devices, which will become effective on June 1, 2021, (the New MDR) (医疗器械监督管理条例) to replace the current Medical Device Regulations amended in 2017 (the Old MDR).

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)